Sensei Biotherapeutics, Inc. (SNSE) Earnings
Sensei Biotherapeutics, Inc. is expected to report next earnings on August 4, 2026 (in NaN days), with a consensus EPS estimate of $-3.34. SNSE has beaten EPS estimates in 7 of its last 12 reported quarters (average surprise -5266.9% over the last four).
Next earnings
Aug 4, 2026in NaN days
EPS est $-3.34 · Revenue est —
Track record
Beat EPS in 7 of 12 quarters
Avg surprise -5266.9% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 15, 2026 | $-0.62 | $-131.45 | -21101.6% | — | — |
| Mar 30, 2026 | $-4.81 | $-3.74 | +22.2% | — | — |
| Nov 14, 2025 | $-4.11 | $-3.62 | +11.9% | $-5M | — |
| Mar 28, 2025 | $-5.40 | $-5.40 | +0.0% | — | — |
| Nov 14, 2024 | $-6.20 | $-5.80 | +6.5% | — | — |
| May 9, 2024 | $-5.80 | $-6.40 | -10.3% | — | — |
| Feb 28, 2024 | $-6.40 | $-6.00 | +6.3% | — | — |
| Aug 3, 2023 | $-6.40 | $-6.20 | +3.1% | — | — |
| Mar 23, 2023 | $-0.40 | $-0.40 | +0.5% | — | — |
| Aug 9, 2022 | $-8.00 | $-6.80 | +15.0% | — | — |
| Mar 10, 2022 | $-6.80 | $-5.80 | +14.7% | — | — |
| Aug 4, 2021 | $-6.00 | $-6.40 | -6.7% | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.